Skip to content

MDMA: all studies

Page 42 of 345: studies 411 to 420 of 3,446, newest first. Back to the MDMA overview

Research

Repeated use of 3,4-methylenedioxymethamphetamine is associated with the resilience in mice after chronic social defeat stress: A role of gut-microbiota-brain axis.

Psychiatry Research December 21, 2022 Youge Qu, Akifumi Eguchi, Xiayun Wan et al.

3,4-Methylenedioxymethamphetamine (MDMA), the most widely used illicit compound worldwide, is the most attractive therapeutic drug for post-traumatic stress disorder (PTSD). Recent observational studies of US adults demonstrated that lifetime MDMA use was associated with lower risk of depression. Here, we examined whether repeated administration of MDMA can affect resilience versus...

DOI: 10.1016/j.psychres.2022.115020 (opens in new tab) MDMA Brain Animals Mice, inbred c57bl +10

Ecstasy metabolites and monoamine neurotransmitters upshift the Na+/K+ ATPase activity in mouse brain synaptosomes.

Archives of Toxicology December 2022 Daniel José Barbosa, João Paulo Capela, Luísa Maria Ferreira et al.

3,4-Methylenedioximethamphetamine (MDMA; "ecstasy") is a psychotropic drug with well-known neurotoxic effects mediated by hitherto not fully understood mechanisms. The Na+- and K+-activated adenosine 5'-triphosphatase (Na+/K+ ATPase), by maintaining the ion gradient across the cell membrane, regulates neuronal excitability. Thus, a perturbation of its function strongly impacts cell homeostasis,...

DOI: 10.1007/s00204-022-03370-7 (opens in new tab) Full text (opens in new tab) 3,4-Methylenedioxymethamphetamine MDMA MDMA Brain Effects MDMA Metabolites Monoamine neurotransmitters +2

Psicoterapia Assistida por MDMA: um Novo Paradigma no Tratamento da Perturbação de Stress Pós‐Traumático Resistente?

Revista Portuguesa de Psiquiatria e Saúde Mental November 27, 2022 Pedro Mota, Joana Proença Becker, Manuel João Quartilho

A perturbação de stress pós‐traumático (PSPT) é uma doença psiquiátrica comum, geralmente crónica, com severas implicações na qualidade de vida da pessoa afetada e da sua família, e que tem vindo a apresentar um crescente reconhecimento enquanto problema de Saúde Pública. Nas últimas duas décadas, estudos clínicos com 3,4‐metilenodioximetanfetamina (MDMA) têm vindo a demonstrar...

Evaluating the attitudes of mental health professionals towards trials of MDMA: a randomised vignette trial

BMJ Open November 26, 2022 Nick Glozier, Ben Colagiuri, Dean J Wright 3 citations

Objectives To compare attitudes of mental health (MH) professionals towards trials of methylenedioxymethamphetamine-assisted psychotherapy (MDMA-AP), with a neutrally labelled pharmacotherapy trial.Design A randomised controlled vignette study design, with experimenters blinded to group condition.Setting Participants were recruited online via professional societies.Participants Psychiatrists,...

Size matters: comparing the MDMA content and weight of ecstasy tablets submitted to European drug checking services in 2012–2021

Drugs, Habits and Social Policy November 24, 2022 Ruben Q Vrolijk, Fiona Measham, Adrià Quesada et al.

Purpose The 3,4-methylenedioxymetamphetamine (MDMA) content in ecstasy tablets has increased enormously throughout Europe across the past decade. This study aims to determine whether this is caused by the production of “stronger” tablets (more mg MDMA per mg of tablet), or if tablets have simply been getting larger and heavier (more mg of tablet in total). Design/methodology/approach A data set...

Šamanizem na Slovenskem? Dileme o pojmih in pojavih šamanizma, obsedenosti in ekstazeShamanism on Slovenian Territory? Dilemmas Concerning the Phenomena of Shamanism, Spirit Possession and Ecstasy

Studia Mythologica Slavica November 23, 2022 Zmago Šmitek 1 citation

Are there elements of shamanism in Slovenian folklore tradition, or is it more adequate to use terms like spirit possession or ecstasy? The author’s conclusion, which is based Slovenian data and on comparative literature, is that it is difficult to differentiate these terms in practice. He also explains the possible original meaning of the names kresnik and vedomec.

Methylone and MDMA Pharmacokinetics Following Controlled Administration in Humans

International Journal of Molecular Sciences November 23, 2022 Lourdes Poyatos, Alfredo Fabrizio Lo Faro, Diletta Berardinelli et al. 22 citations

The aim of this study is to define, for the first time, human methylone and HMMC plasma pharmacokinetics following controlled administration of 50–200 mg methylone to 12 male volunteers. A new LC-MS/MS method was validated to quantify methylone, MDMA, and their metabolites in plasma. The study was a randomized, cross-over, double-blinded and placebo-controlled study, with a total of 468 plasma...

Effects of 3,4-methylenedioxymethamphetamine and methamphetamine on motor vehicle driving performance: A systematic review of experimental and observational studies.

Journal of Forensic Sciences November 21, 2022 Ian R McGrane, Nathan C Ramsbacher, William C Rook et al.

Methamphetamine (METH) and 3,4-methylenedioxymethamphetamine (MDMA) are common drugs of abuse and driving under their influence may occur in 1 million people yearly in the United States. This systematic review fills the currently unmet need in understanding the effects of METH and MDMA on motor vehicle driving performance (MVP) and provides insight into the forensic community. A PubMed search...

DOI: 10.1111/1556-4029.15179 (opens in new tab) MDMA Humans N-methyl-3,4-methylenedioxyamphetamine Motor vehicles +5

Impact of fluoxetine preexposure on MDMA-induced taste avoidance in male and female rats.

Experimental and Clinical Psychopharmacology November 17, 2022 Sara K Bowman, Shihui Huang, Marissa E Vasquez et al.

The use of both prescription and illicit drugs creates the potential for drug interactions as a function of both pharmacokinetic and pharmacodynamic processes. One such interaction is that of fluoxetine and methylenedioxymethamphetamine (MDMA) in which fluoxetine attenuates the positive-like effects of MDMA. The present work extends the analysis of their interaction by examining the impact of...

DOI: 10.1037/pha0000610 (opens in new tab) Full text (opens in new tab) Animals Rats, sprague-dawley N-methyl-3,4-methylenedioxyamphetamine Fluoxetine +3

MDMA for the treatment of misophonia, a proposal.

Frontiers in Psychiatry November 10, 2022

Misophonia is a disorder characterized by negative physical and emotional reactions to certain trigger sounds, such as chewing food. Up to 50% of population samples endorse some symptoms of misophonia, with about 20% having symptoms that impair normal life functioning. Most misophonia patients exhibit intense negative emotions and autonomic arousal (the fight-flight-freeze response) in response...